化合物 9-(3-DEOXY-3-FLUORO-Β-D-RIBOFURANOSYL)-6-[6-(4-METHYLPIPERAZINYL) PYRIDIN-3-YL]PURINE
| 中文名称 | 化合物 9-(3-DEOXY-3-FLUORO-Β-D-RIBOFURANOSYL)-6-[6-(4-METHYLPIPERAZINYL) PYRIDIN-3-YL]PURINE |
|---|---|
| 中文同义词 | 化合物 9-(3-DEOXY-3-FLUORO-Β-D-RIBOFURANOSYL)-6-[6-(4-METHYLPIPERAZINYL) PYRIDIN-3-YL]PURINE;9-(3-Deoxy-3-fluoro-尾-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl)pyridin-3-yl]purine;[9-(3-脱氧-3-氟-β-D-呋喃核糖基)-6-[6-(4-甲基哌嗪yl)吡啶-3-基]嘌呤] |
| 英文名称 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine |
| 英文同义词 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine;9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine;9-(3'-Deoxy-3'-fluoro-b-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl)pyridin-3-yl]purine;9H-Purine, 9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]- |
| CAS号 | 1612191-99-7 |
| 分子式 | C20H24FN7O3 |
| 分子量 | 429.46 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1612191-99-7.mol |
| 结构式 | ![化合物 9-(3-DEOXY-3-FLUORO-Β-D-RIBOFURANOSYL)-6-[6-(4-METHYLPIPERAZINYL) PYRIDIN-3-YL]PURINE 结构式](CAS/20211123/GIF/1612191-99-7.gif) |
化合物 9-(3-DEOXY-3-FLUORO-Β-D-RIBOFURANOSYL)-6-[6-(4-METHYLPIPERAZINYL) PYRIDIN-3-YL]PURINE 性质
| 沸点 | 727.8±70.0 °C(Predicted) |
|---|---|
| 密度 | 1.61±0.1 g/cm3(Predicted) |
| 酸度系数(pKa) | 12.43±0.70(Predicted) |
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine 是一种嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性，靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制 DNA 合成，诱导细胞凋亡 (apoptosis) 等。